Clinical Trials Directory

Trials / Unknown

UnknownNCT03584958

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Comparing Refractive and Visual Outcomes of Minimally Invasive and Traditional Glaucoma Surgeries

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Wills Eye · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to evaluate refractive and visual outcomes in glaucoma patients who will be having either traditional glaucoma surgery or minimally invasive glaucoma surgery, also known as MIGS.

Detailed description

There is an increasing number of surgical options to lower intraocular pressure (IOP) in patients with glaucoma and ocular hypertension performed with or without concurrent cataract surgery. Today, patients undergoing glaucoma surgery have increasingly higher expectations for their postoperative visual outcomes. Therefore, it is important to understand the influence of various glaucoma surgical procedures on refractive outcomes. This information would aid in patient and surgical procedure selection, pre-operative counseling to set appropriate expectations and may help surgeons adjust their plans and techniques to improve visual outcomes. The advent of minimally invasive glaucoma surgery (MIGS) procedures further highlights the importance of studying refractive outcomes as many of these surgeries are being performed earlier in the glaucoma severity spectrum where central visual potential is still preserved. Furthermore, this class of surgeries is often performed in combination with cataract surgery. There remains a lack of data regarding refractive outcomes in patients who have had phaco-iStent, phaco-Cypass, as well as goniotomy (Kahook dual blade (KDB) gonioscopy assisted transluminal trabeculotomy), and Xen gel stent implantation with or without cataract surgery. This information would help during pre-operative patient discussions and lens selection in the context of a combined procedure.

Conditions

Timeline

Start date
2018-08-01
Primary completion
2022-12-31
Completion
2023-06-30
First posted
2018-07-12
Last updated
2022-03-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03584958. Inclusion in this directory is not an endorsement.